BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12852255)

  • 1. Peroxisome proliferator-activated receptors and the cardiovascular system.
    Chen YE; Fu M; Zhang J; Zhu X; Lin Y; Akinbami MA; Song Q
    Vitam Horm; 2003; 66():157-88. PubMed ID: 12852255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
    Schoonjans K; Staels B; Auwerx J
    Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J; Wójcicka G; Jamroz A
    Postepy Hig Med Dosw; 2003; 57(2):199-217. PubMed ID: 12866356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms of action of PPARs.
    Berger J; Moller DE
    Annu Rev Med; 2002; 53():409-35. PubMed ID: 11818483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
    Evdokimova MA; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
    Berger J; Wagner JA
    Diabetes Technol Ther; 2002; 4(2):163-74. PubMed ID: 12079620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors, orphans with ligands and functions.
    Schoonjans K; Martin G; Staels B; Auwerx J
    Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
    Fruchart JC; Duriez P; Staels B
    Curr Opin Lipidol; 1999 Jun; 10(3):245-57. PubMed ID: 10431661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peroxisome proliferator-activated receptor(PPAR)--structure, function, tissue distribution, gene expression].
    Takeyama K; Kodera Y; Suzawa M; Kato S
    Nihon Rinsho; 2000 Feb; 58(2):357-63. PubMed ID: 10707558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease.
    Takano H; Komuro I
    J Diabetes Complications; 2002; 16(1):108-14. PubMed ID: 11872377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N; Vamecq J
    Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and additional vascular effects of thiazolidinediones.
    Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
    Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
    Plutzky J
    Curr Atheroscler Rep; 2000 Jul; 2(4):327-35. PubMed ID: 11122762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid metabolism related nuclear receptor--the structure, function, expression and classification of peroxisome proliferation-activated receptor (PPAR)].
    Kawada T
    Nihon Rinsho; 1998 Jul; 56(7):1722-8. PubMed ID: 9702044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.
    Ferré P
    Diabetes; 2004 Feb; 53 Suppl 1():S43-50. PubMed ID: 14749265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.